ArticleScientific reports2022
Incorporation of engineered nanoparticles of biochar and fly ash against bacterial leaf spot of pepper.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Engineered biochar nanocomposites: integrating nanotechnology with carbon-based materials to enhance plant resilience against biotic and abiotic stresses.Frontiers in plant science · 2026Review
- Article
- Degradation of fluoride in groundwater by electrochemical fixed bed system with bauxite: performance and synergistic catalytic mechanism.RSC advances · 2024Article
- Definitive Review of Nanobiochar.ACS omega · 2024Review
- Nanoparticles in plant resistance against bacterial pathogens: current status and future prospects.Molecular biology reports · 2024Review
- Recent trends and economic significance of modified/functionalized biochars for remediation of environmental pollutants.Scientific reports · 2024Review
- Demonstration of the synergistic effect of biochar andFrontiers in microbiology · 2024Article
- Biological characteristics of the bacteriophage LDT325 and its potential application against the plant pathogenFrontiers in microbiology · 2024Article
- Bacteriophage LDT325 enhancesFrontiers in microbiology · 2024Article
- Physiological and biochemical characterization of biochar-induced resistance against bacterial wilt of eggplants.Royal Society open science · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In agriculture, the search for higher net profit is the main challenge in the economy of the producers and nano biochar attracts increasing interest in recent years due to its unique environmental behavior and increasing the productivity of plants by inducing resistance against phytopathogens. The effect of rice straw biochar and fly ash nanoparticles (RSBNPs and FNPs, respectively) in combination with compost soil on bacterial leaf spot of pepper caused by Xanthomonas campestris pv. vesicatoria was investigated both in vitro and in vivo. The application of nanoparticles as soil amendment significantly improved the chili pepper plant growth. However, RSBNPs were more effective in enhancing the above and belowground plant biomass production. Moreover, both RSBNPs and FNPs, significantly reduced (30.5 and 22.5%, respectively), while RSBNPs had shown in vitro growth inhibition of X. campestris pv. vesicatoria by more than 50%. The X-ray diffractometry of RSBNPs and FNPs highlighted the unique composition of nano forms which possibly contributed in enhancing the plant defence against invading X. campestris pv. vesicatoria. Based on our findings, it is suggested that biochar and fly ash nanoparticles can be used for reclaiming the problem soil and enhance crop productivity depending upon the nature of the soil and the pathosystem under investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.